heart disease
Dr. Dee Dee Wang, cardiologist and section head of cardiac imaging at NCH Rooney Heart Institute, joined MobiHealthNews to discuss a new technology that identifies heart disease years before patients present with symptoms.
The partnership will focus on building AI tools that accelerate heart disease and cancer detection with the aim of reducing diagnostic turnaround times.
A Singaporean startup leverages Asian-specific databases in making heart disease risk assessments.
The funding comes more than a year after the company closed an oversubscribed $31.4 million Series B round.
The company will use the funds to expand its commercial growth and clinical-evidence generation.
The company is also recruiting a CEO in the US.
Powered by AI, it has over 80% accuracy in detecting valvular heart disease.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
The risk assessment tool can potentially determine if plaque build-up has narrowed a patient's coronary arteries.
The AHA says future developments in health technology aimed at seniors should address this demographic’s barriers to adoption.